Genetic background affects susceptibility to mammary hyperplasias and carcinomas in ApcMin/+ mice

Amy Rapaich Moser, Laura F. Hegge, Robert Cardiff

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Treatment of female C57BL/6J (B6) mice carrying the mutant Min allele of the adenomatous polyposis coil (Apc) gene with ethylnitrosourea (ENU) results in ∼90% of mice developing an average of three mammary tumors within 65 days. As a first step in the identification of loci modifying susceptibility to ENU-induced mammary tumors and hyperplasias, we have tested ENU-treated ApcMin/+ (Min/+) mice on several hybrid backgrounds for susceptibility to mammary and intestinal tumors. C57BR/cdJ×B6 (BRB6) Min/+ mice were more sensitive to development of mammary squamous cell carcinomas than B6 Min/+ mice. In contrast, Min/+ hybrids between B6 and FVB/NTac (FVB), 129X1/SvJ (129X1), and 129S6/SvEvTac (129S6) were all significantly more resistant to mammary carcinoma development. However, mice from these three crosses developed more focal mammary hyperplasias than did the B6 or BRB6 Min/+ mice. Susceptibility to intestinal tumors was independent of mammary tumor susceptibility in most hybrids. These results indicate that genetic background can affect independently the phenotypes conferred by the Min allele of Apc.

Original languageEnglish (US)
Pages (from-to)3480-3485
Number of pages6
JournalCancer Research
Volume61
Issue number8
StatePublished - Apr 15 2001

Fingerprint

Hyperplasia
Breast Neoplasms
Ethylnitrosourea
Breast
Alleles
Genetic Background
Squamous Cell Carcinoma
Phenotype
Genes
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Genetic background affects susceptibility to mammary hyperplasias and carcinomas in ApcMin/+ mice. / Moser, Amy Rapaich; Hegge, Laura F.; Cardiff, Robert.

In: Cancer Research, Vol. 61, No. 8, 15.04.2001, p. 3480-3485.

Research output: Contribution to journalArticle

@article{69252e4f47d1484dba2abceea7b0acba,
title = "Genetic background affects susceptibility to mammary hyperplasias and carcinomas in ApcMin/+ mice",
abstract = "Treatment of female C57BL/6J (B6) mice carrying the mutant Min allele of the adenomatous polyposis coil (Apc) gene with ethylnitrosourea (ENU) results in ∼90{\%} of mice developing an average of three mammary tumors within 65 days. As a first step in the identification of loci modifying susceptibility to ENU-induced mammary tumors and hyperplasias, we have tested ENU-treated ApcMin/+ (Min/+) mice on several hybrid backgrounds for susceptibility to mammary and intestinal tumors. C57BR/cdJ×B6 (BRB6) Min/+ mice were more sensitive to development of mammary squamous cell carcinomas than B6 Min/+ mice. In contrast, Min/+ hybrids between B6 and FVB/NTac (FVB), 129X1/SvJ (129X1), and 129S6/SvEvTac (129S6) were all significantly more resistant to mammary carcinoma development. However, mice from these three crosses developed more focal mammary hyperplasias than did the B6 or BRB6 Min/+ mice. Susceptibility to intestinal tumors was independent of mammary tumor susceptibility in most hybrids. These results indicate that genetic background can affect independently the phenotypes conferred by the Min allele of Apc.",
author = "Moser, {Amy Rapaich} and Hegge, {Laura F.} and Robert Cardiff",
year = "2001",
month = "4",
day = "15",
language = "English (US)",
volume = "61",
pages = "3480--3485",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Genetic background affects susceptibility to mammary hyperplasias and carcinomas in ApcMin/+ mice

AU - Moser, Amy Rapaich

AU - Hegge, Laura F.

AU - Cardiff, Robert

PY - 2001/4/15

Y1 - 2001/4/15

N2 - Treatment of female C57BL/6J (B6) mice carrying the mutant Min allele of the adenomatous polyposis coil (Apc) gene with ethylnitrosourea (ENU) results in ∼90% of mice developing an average of three mammary tumors within 65 days. As a first step in the identification of loci modifying susceptibility to ENU-induced mammary tumors and hyperplasias, we have tested ENU-treated ApcMin/+ (Min/+) mice on several hybrid backgrounds for susceptibility to mammary and intestinal tumors. C57BR/cdJ×B6 (BRB6) Min/+ mice were more sensitive to development of mammary squamous cell carcinomas than B6 Min/+ mice. In contrast, Min/+ hybrids between B6 and FVB/NTac (FVB), 129X1/SvJ (129X1), and 129S6/SvEvTac (129S6) were all significantly more resistant to mammary carcinoma development. However, mice from these three crosses developed more focal mammary hyperplasias than did the B6 or BRB6 Min/+ mice. Susceptibility to intestinal tumors was independent of mammary tumor susceptibility in most hybrids. These results indicate that genetic background can affect independently the phenotypes conferred by the Min allele of Apc.

AB - Treatment of female C57BL/6J (B6) mice carrying the mutant Min allele of the adenomatous polyposis coil (Apc) gene with ethylnitrosourea (ENU) results in ∼90% of mice developing an average of three mammary tumors within 65 days. As a first step in the identification of loci modifying susceptibility to ENU-induced mammary tumors and hyperplasias, we have tested ENU-treated ApcMin/+ (Min/+) mice on several hybrid backgrounds for susceptibility to mammary and intestinal tumors. C57BR/cdJ×B6 (BRB6) Min/+ mice were more sensitive to development of mammary squamous cell carcinomas than B6 Min/+ mice. In contrast, Min/+ hybrids between B6 and FVB/NTac (FVB), 129X1/SvJ (129X1), and 129S6/SvEvTac (129S6) were all significantly more resistant to mammary carcinoma development. However, mice from these three crosses developed more focal mammary hyperplasias than did the B6 or BRB6 Min/+ mice. Susceptibility to intestinal tumors was independent of mammary tumor susceptibility in most hybrids. These results indicate that genetic background can affect independently the phenotypes conferred by the Min allele of Apc.

UR - http://www.scopus.com/inward/record.url?scp=0035870247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035870247&partnerID=8YFLogxK

M3 - Article

C2 - 11309311

AN - SCOPUS:0035870247

VL - 61

SP - 3480

EP - 3485

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 8

ER -